The Enterprise Value as of December 2025 (TTM) for Nymox Pharmaceutical Corporation (NYMXF) is 5.60M

According to Nymox Pharmaceutical Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 5.60M. This represents a change of -80.77% compared to the average of 29.11M of the last 4 quarters.

Nymox Pharmaceutical Corporation (NYMXF) Historical Enterprise Value (quarterly & annually)

How has NYMXF Enterprise Value performed in the past?

The mean historical Enterprise Value of Nymox Pharmaceutical Corporation over the last ten years is 98.00M. The current 5.60M Enterprise Value has changed 471.25% with respect to the historical average. Over the past ten years (40 quarters), NYMXF's Enterprise Value was at its highest in in the September 2021 quarter at 169.83M. The Enterprise Value was at its lowest in in the December 2024 quarter at 9.35M.

Nymox Pharmaceutical Corporation (NYMXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Nymox Pharmaceutical Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nymox Pharmaceutical Corporation (NYMXF) Average Enterprise Value

How has NYMXF Enterprise Value performed in the past?

The current Enterprise Value of Nymox Pharmaceutical Corporation (NYMXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Nymox Pharmaceutical Corporation (NYMXF) Enterprise Value vs. Peers

How is NYMXF’s Enterprise Value compared to its peers?

Nymox Pharmaceutical Corporation’s Enterprise Value is less than Hemostemix Inc. (20.00M), greater than HOOKIPA Pharma Inc. (-28576470.00), greater than Devonian Health Group Inc. (5.00M), less than Algorae Pharmaceuticals Limited (21.43M), less than EOM Pharmaceuticals Holdings, Inc. (22.39M), less than Sirona Biochem Corp. (9.38M), less than Inhibitor Therapeutics, Inc. (5.72M), less than Oxford BioDynamics Plc (6.37M), less than ALR Technologies Inc. (19.15M), less than Valeo Pharma Inc. (57.68M),

Build a custom stock screener for Nymox Pharmaceutical Corporation (NYMXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nymox Pharmaceutical Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nymox Pharmaceutical Corporation (NYMXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nymox Pharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.